Chloroquine stimulates nitric oxide synthesis in murine, porcine, and human endothelial cells

Journal of Clinical Investigation

Volumn 102, Issue 3, 1998, Pages 595-605

  Ghigo, Dario ^a,c   Aldieri, Elisabetta ^a   Todde, Roberta ^a   Costamagna, Costanzo ^a   Garbarino, Giovanni ^b   Pescarmona, Gianpiero ^a   Bosia, Amalia ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c Dipto di Genet Biologia/Biochim   (Italy)

Author keywords

Ammonium chloride desferrioxamine; Ferric nitrilotriacetate; Lysosomotropic agents; Ornithine decarboxylase

Indexed keywords

AMMONIUM CHLORIDE; CANAVANINE; CHLOROQUINE; DEFEROXAMINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRILOTRIACETATE IRON; ORNITHINE DECARBOXYLASE;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME INDUCTION; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; IRON METABOLISM; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SWINE;

EID: 0032145099     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI1052     Document Type: Article

References (75)

1. Nathan, C. 1992. Nitric oxide as a secretory product of mammalian cells. FASEB (Fed. Am. Soc. Exp. Biol.) J. 6:3051-3064.
2. Gross, S.S., and M.S. Wolin. 1995. Nitric oxide: pathophysiological mechanisms. Ann Rev. Physiol. 57:737-769.
3. Palme, R.M.J., D.S. Ashton, and S. Moncada. 1988. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 333:664-666.
4. Palmer, R.M.J., and S. Moncada. 1989. A novel citrulline-forming enzyme implicated in the formation of nitric oxide by vascular endothelial cells. Biochem. Biophys. Res. Commun. 158:348-352.
5. Knowles, R.G., and S. Moncada. 1994. Nitric oxide synthases in mammals. Biochem. J. 298:249-258.
6. Schmidt, H.H.H.W., and U. Walter. 1994. NO at work. Cell. 78:919-925.
7. Clark, I.A., K.A. Rockett, and W.B. Cowden. 1991. Proposed link between cytokines, nitric oxide and human cerebral malaria. Parasitol. Today. 7: 205-207.
8. Clark, I.A., K.A. Rockett, and W.B. Cowden. 1992. Possible central role of nitric oxide in conditions clinically similar to cerebral malaria. Lancet. 340: 894-896.
9. Rockett, K.A., M.M. Awburn, B.B. Aggarwal, W.B. Cowden, and I.A. Clark. 1992. In vivo induction of nitrite and nitrate by tumor necrosis factor, lymphotoxin, and interleukin-1: possible roles in malaria. Infect. Immun. 60: 3725-3730.
10. Ghigo, D., R. Todde, H. Ginsburg, C. Costamagna, P. Gautret, F. Bussolino, D. Ulliers, G. Giribaldi, E. Deharo, G. Gabrielli, G. Pescarmona, and A. Bosia. 1995. Erythrocyte stages of Plasmodium falciparum exhibit a high nitric oxide synthase (NOS) activity and release an NOS-inducing soluble factor. J. Exp. Med. 182:677-688.
11. Mellouk, S., S.J. Green, C.A. Nacy, and S.L. Hoffman. 1991. IFN-γ inhibits development of Plasmodium berghei exoerythrocytic stages in hepatocytes by an L-arginine-dependent effector mechanism. J. Immunol. 146:3971-3976.
12. Nüssler, A., J.-C. Drapier, L. Renia, S. Pied, F. Miltgen, M. Gentilini, and D. Mazier. 1991. L-arginine-dependent destruction of intrahepatic malaria parasites in response to tumor necrosis factor and/or interleukin 6 stimulation. Eur. J. Immunol. 21:227-230.
13. Rockett, K.A., M.M. Awburn, W.B. Cowden, and I.A. Clark. 1991. Killing of Plasmodium falciparum in vitro by nitric oxide derivatives. Infect. Immun. 59:3280-3283.
14. Nussler, A.K., L. Rènia, V. Pasquetto, F. Miltgen, H. Matile, and D. Mazier. 1993. In vivo induction of the nitric oxide pathway in hepatocytes after injection with irradiated malaria sporozoites, malaria blood parasites or adjuvants. Eur. J. Immunol. 23:882-887.
15. Mellouk, S., S.L. Hoffman, Z.-Z. Liu, P. de la Vega, T.R. Billiar, and A.K. Nussler. 1994. Nitric oxide-mediated antiplasmodial activity in human and murine hepatocytes induced by gamma interferon and the parasite itself: enhancement by endogenous tetrahydrobiopterin. Infect. Immun. 62:4043-4046.
16. Seguin, M.C., F.W. Klotz, I. Schneider, J.P. Weir, M. Goodbary, M. Slayter, J.J. Raney, J.U. Anjagolu, and S.J. Green. 1994. Induction of nitric oxide synthase protects against malaria in mice exposed to irradiated Plasmodium berghei infected mosquitoes: involvement of interferon g and CD81 T cells. J. Exp. Med. 180:353-358.
17. McCall, T., and P. Vallance. 1992. Nitric oxide takes centre-stage with newly defined roles. Trends Pharmacol. Sci. 13:1-6.
18. Taylor-Robinson, A.W., R.S. Phillips, A. Severn, S. Moncada, and F.Y. Liew. 1993. The role of TH1 and TH2 cells in a rodent malaria infection. Science. 260:1931-1934.
19. Wellems, T.E. 1992. How chloroquine works. Nature. 355:108-109.
20. Picot, S., F. Peyron, A. Donadille, J.-P. Vuillez, G. Barbe, and P. Ambroise-Thomas. 1993. Chloroquine-induced inhibition of the production of TNF, but not IL-6, is affected by disruption of iron metabolism. Immunol. 80: 127-133.
21. Landewè, R.B.M., A.M.M. Miltenburg, M.J.A. Verdonk, C.L. Verweij, F.C. Breedveld, M.R. Daha, and B.A.C. Dijkmans. 1995. Chloroquine inhibits T cell proliferation by interfering with IL-2 production and responsiveness. Clin. Exp. Immunol. 102:144-151.
22. Slater, A.F.G., and A. Cerami. 1992. Inhibition by chloroquine of a novel haem polymerase enzyme activity in malaria trophozoites. Nature. 355: 167-169.
23. Krogstad, D.J., and P.H. Schlesinger. 1987. Acid-vesicle function, intracellular pathogens, and the action of chloroquine against Plasmodium falciparum. N. Engl. J. Med. 317:542-549.
24. Williams, R.L., S.A. Courtneidge, and E.F. Wagner. 1988. Embryonic lethalities and endothelial tumors in chimeric mice expressing polyoma virus middle T oncogene. Cell. 52:121-131.
25. Gryglewski, R.J., S. Moncada, and R.M.J. Palmer. 1986. Bioassay of prostacyclin and endothelium-derived relaxing factor (EDRF) from porcine aortic endothelial cells. Br. J. Pharmacol. 87:685-694.
26. Bredt, D.S., and S.H. Snyder. 1989. Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc. Natl. Acad. Sci. USA. 86:9030-9033.
27. Knowles, R.G., M. Palacios, R.M.J. Palmer, and S. Moncada. 1989. Formation of a nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase. Proc. Natl. Acad. Sci. USA. 86:5159-5162.
28. Gross, S.S., E.A. Jaffe, R. Levi, and R.G. Kilbourn. 1991. Cytokine-activated endothelial cells express an isotype of nitric oxide synthase which is tetrahydrobiopterin-dependent, calmodulin-independent and inhibited by arginine analogues with a rank-order of potency characteristic of activated macrophages. Biochem. Biophys. Res. Commun. 178:823-829.
29. Chirgwin, J.M., A.E. Przybyla, R.M. MacDonald, and W.J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 18:5294-5299.
30. Maniatis, T., E.F. Fritsch, and J. Sambrook. 1982. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY. 1.1-18.86.
31. Kao, J.P.Y., A.T. Harootunian, and R.Y. Tsien. 1989. Photochemically generated cytosolic calcium pulses and their detection by Fluo-3. J. Biol. Chem. 264:8179-8184.
32. Rabie, A., R.J. Simpson, A. Bomford, D. Cunninghame-Graham, T.J. Peters. 1995. Relationship between duodenal cytosolic aconitase activity and iron status in the mouse. Biochim. Biophys. Acta. 1245:414-420.
33. Schwarzer, E., F. Turrini, and P. Arese. 1994. A luminescence method for the quantitative determination of phagocytosis of erythrocytes, of malaria-parasitized erythrocytes and of malarial pigment. Br. J. Haematol. 88:740-745.
34. Thomas, J.A., R.N. Buschbaum, A. Zimniak, and E. Racker. 1979. Intracellular pH measurements in Ehrlich ascites tumor cells using spectroscopic probes generated in situ. Biochemistry. 18:2210-2218.
35. + antiport of Plasmodium falciparum membrane. J. Cell. Physiol. 154:527-534.
36. + exchanger in the colony-stimulating-factor-induced ornithine decarboxylase activity and proliferation of the human cell line M-07e. J. Cell. Physiol. 145:147-154.
37. Kueng, W., E. Silber, and U. Eppenberger. 1989. Quantification of cells cultured on 96-well plates. Anal. Biochem. 182:16-19.
38. Pegg, A.E. 1986. Recent advances in the biochemistry of polyamines in eukaryotes. Biochem. J. 234:249-262.
39. Byrd, T.F., and M.A. Horwitz. 1991. Chloroquine inhibits the intracellular multiplication of Legionella pneumophila by limiting the availability of iron. J. Clin. Invest. 88:351-357.
40. Rouault, T.A., and R.D. Klausner. 1996. Iron-sulfur clusters as biosensors of oxidants and iron. Trends Biochem. Sci. 21:174-177.
41. Ayajiki, K., M. Kindermann, M. Hecker, I. Fleming, and R. Busse. 1996. Intracellular pH and tyiosine phosphorylation but not calcium determine shear stress-induced nitric oxide production in native endothelial cells. Circ. Res. 78: 750-758.
42. Augustijns, P., P. Geusens, and N. Verbeke. 1992. Chloroquine levels in blood during chronic treatment of patients with rheumatoid arthritis. Eur. J. Clin. Pharmacol. 42:429-433.
43. Edwards, G., S. Looareesuwan, A.J. Davies, Y. Wattanagoon, R.E. Phillips, and D.A. Warrell. 1988. Pharmacokinetics of chloroquine in Thais: plasma and red-cell concentrations following an intravenous infusion to healthy subjects and patients with Plasmodium vivax malaria. Br. J. Clin. Pharmacol. 25:477-485.
44. Phillips, R.E., D.A. Warrell, G. Edwards, Y. Galagedera, R.D. Theakston, D.T. Abeysekera, and P. Dissanayaka. 1986. Divided dose intramuscular regimen and single dose subcutaneous regimen for chloroquine: plasma concentrations and toxicity in patients with malaria. Br. Med. J. 293:13-16.
45. Nathan, C., and Q.-W. Xie. 1994. Nitric oxide synthases: roles, tolls, and controls. Cell. 78:915-918.
46. Chandra, S., G. Adhikary, R. Sikdar, and P.C. Sen. 1992. The in vivo inhibition of transport enzyme activities by chloroquine in different organs of rat is reversible. Mol. Cell. Biochem. 118:15-21.
47. Michel, T., G.K. Li, and L. Busconi. 1993. Phosphorylation and subcellular translocation of endothelial nitric oxide synthase. Proc. Natl. Acad. Sci. USA. 90:6252-6256.
48. Michel, T., and O. Feron. 1997. Nitric oxide synthases: which, where, how, and why? J. Clin. Invest. 100:2146-2152.
49. Molina y Vedia, L., B. McDonald, B. Reep, B. Brüne, M. Di Silvio, T.R. Billiar, and E. Lapetina. 1992. Nitric oxide-induced S-nitrosylation of glyceraldehyde-3-phosphate dehydrogenase inhibits enzymatic activity and increases endogenous ADP-ribosylation. J. Biol. Chem. 267:24929-24932.
50. Stuehr, D.J., and C.F. Nathan. 1989. Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J. Exp. Med. 169:1543-1555.
51. Stamler, J.S., D.I. Simon, J.A. Osborne, M.E. Mullins, O. Jaraki, T. Michel, D.J. Singel, and J. Loscalzo. 1992. S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. Proc. Natl. Acad. Sci. USA. 89:444-448.
52. Lepoivre, M., F. Fieschi, J. Coves, L. Thelander, and M. Fontecave. 1991. Inactivation of ribonucleotide reductase by nitric oxide. Biochem. Biophys. Res. Commun. 179:442-448.
53. Zhang, J., V.L. Dawson, T.M. Dawson, and S.H. Snyder. 1994. Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. Science. 263: 687-689.
54. Wink, D.A., K.S. Kasprzak, C.M. Maragos, R.K. Elespuru, M. Misra, T.M. Dunams, T.A. Cebula, W.H. Koch, A.W. Andrews, J.S. Allen, and L.K. Keefer. 1991. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science. 254:1001-1003.
55. Pegg, A.E. 1988. Polyamine metabolism and its importance in neoplastic growth and as a target for chemotherapy. Cancer Res. 48:759-774.
56. Octave, J.-N., Y.-J. Schneider, P. Hoffmann, A. Trouet, and R.R. Crichton. 1979. Transferrin protein and iron uptake by cultured rat fibroblasts. FEBS Lett. 108:127-130.
57. Karin, M., and B. Mintz. 1981. Receptor-mediated endocytosis of transferrin in developmentally totipotent mouse teratocarcinoma stem cells. J. Biol. Chem. 256:3245-3252.
58. Iacopetta, B.J., and E.H. Morgan. 1983. The kinetics of transferrin endocytosis and iron uptake from transferrin in rabbit reticulocytes. J. Biol. Chem. 258:9108-9115.
59. Armstrong, N.J., and E.H. Morgan. 1983. The effect of lysosomotrophic bases and inhibitors of transglutaminase on iron uptake by immature erythroid cells. Biochim. Biophys. Acta. 762:175-186.
60. Breuer, W., S. Epsztejn, and Z.I. Cabantchik. 1995. Iron acquired from transferrin by K562 cells is delivered into a cytoplasmic pool of chelatable iron(II). J. Biol. Chem. 270:24209-24215.
61. Weiss, G., G. Werner-Felmayer, E.R. Werner, K. Grünewald, H. Wachter, and M.W. Hentze. 1994. Iron regulates nitric oxide synthase activity by controlling nuclear transcription. J. Exp. Med. 180:969-976.
62. Newman, S.L., L. Gootee, G. Brunner, and G.S. Deepe, Jr. 1994. Chloroquine induces human macrophage killing of Histoplasma capsulatum by limiting the availability of intracellular iron and is therapeutic in a murine model of histoplasmosis. J. Clin. Invest. 93:1422-1429.
63. Kremsner, P.G., S. Neifer, T. Rasenack, and U. Bienzle. 1993. Interference by antimalarial drugs with the in-vitro production of reactive nitrogen intermediates by murine macrophages. J. Antimicrob. Chemother. 31:385-392.
64. MacKenzie, A.H. 1983. Dose refinements in long-term therapy of rheumatoid arthritis with antimalarials. Am. J. Med. 75(Suppl.):40-45.
65. Rothe, M.J., and F.A. Kerdel. 1992. Treatment of cutaneous lupus erythematosus. Lupus. 1:351-356.
66. Goenka, M.K., R. Kochhar, B. Tandia, and S.K. Mehta. 1996. Chloroquinc for mild to moderately active ulcerative colitis: comparison with sulfasalazine. Am. J. Gastroenterol. 91:917-921.
67. Sayers, M.E., and D.J. Mazanec. 1992. Use of antimalarial drugs for the treatment of psoriatic arthritis. Am. J. Med. 93:474-475.
68. Lejeùne, P., P. Lagadec, N. Onier, D. Pinard, H. Ohshima, and J.-F. Jeannin. 1994. Nitric oxide involvement in tumor-induced immunosuppression. J. Immunol. 152:5077-5083.
69. Valls, V., J. Ena, and R. Enriquez-De-Salamanca. 1994. Low-dose oral chloroquine in patients with porphyria cutanea tarda and low-moderate iron overload. J. Dermatol. Sci. 7:169-175.
70. Jancinova, V., R. Nosal, and M. Petrikova. 1994. On the inhibitory effect of chloroquine on blood platelet aggregation. Thromb. Res. 74:495-504.
71. White, N.J., K.D. Miller, F.C. Churchill, C. Berry, J. Brown, S.B. Williams, and B.M. Greenwood. 1988. Chloroquine treatment of severe malaria in children. Pharmacokinetics, toxicity, and new dosage recommendations. N. Engl. J. Med. 319:1493-1500.
72. Anigbogu, C.N., S.A. Adigun, I. Inyang, and B.J. Adegunloye. 1993. Chloroquine reduces blood pressure and forearm vascular resistance and increases forearm blood flow in healthy young adults. Clin. Physiol. 13:209-216.
73. Abiose, A.K., M. Grossmann, O. Tangphao, B.B. Hoffman, and T.F. Blaschke. 1997. Chloroquine-induced venodilation in human hand veins. Clin. Pharmacol. Ther. 61:677-683.
74. Espinosa-Aguirre, J.J., J. Ramirez Santos, and C. Cortinas de Nava. 1989. Influence of the Uvr repair system on the mutagenicity of antiparasitic drugs. Mutation Res. 222:161-166.
75. Tegner, R., F.M. Tome, P. Godeau, F. Lhermitte, and M. Fardeau. 1988. Morphological study of peripheral nerve changes induced by chloroquine treatment. Acta Neuropathol. 75:253-260.